Unlock instant, AI-driven research and patent intelligence for your innovation.

A method for detecting tacrolimus precision medicine, primers, PCR reagents and kits

A precision medicine, tacrolimus technology, applied in the field of medical treatment and biological detection, can solve the problems of increasing CYP3A4 enzyme activity, accelerating tacrolimus metabolism, affecting blood drug concentration, etc., so as to improve the positive rate of detection and reduce the clinical The effect of detection cost and simple operation

Active Publication Date: 2022-02-08
JINAN YING SHENG BIOTECH
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are multiple mutation sites in the CYP3A4 gene. The site with the highest mutation rate in Chinese is CYP3A4*1G (or CYP3A4*18B). This mutation will increase the activity of CYP3A4 enzymes, thereby accelerating the metabolism of tacrolimus and affecting blood drug concentration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for detecting tacrolimus precision medicine, primers, PCR reagents and kits
  • A method for detecting tacrolimus precision medicine, primers, PCR reagents and kits
  • A method for detecting tacrolimus precision medicine, primers, PCR reagents and kits

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] Example 1: Design and optimization of primers, and establishment of reaction system

[0079] Through the primer design software on the PharmGKB website, adjust the relevant parameters, complete the PCR amplification and extension primer design of the three SNP sites, export the designed primers and various parameter files, and synthesize the primers. Prepare the amplification primer MIX and the extension primer MIX according to the primer configuration table, and fine-tune the extension primer MIX until it meets the requirements. Primer testing and optimization were then performed. Specific steps are as follows:

[0080] 1. Using the whole blood of patient A with EDTA anticoagulant as a template, the genome was extracted;

[0081] First, add 200 μL of cell lysate to 1 mL of whole blood, centrifuge and pour off the supernatant; add 200 μL of isopropanol to the precipitate to extract nucleic acid, centrifuge and pour off the supernatant; add 200 μL proteinase K to the...

Embodiment 2

[0118] Example 2: Detection of tacrolimus dosage regimen based on genetic polymorphisms analyzed by MALDI-TOF mass spectrometry platform Test method applied to clinical case

[0119] Patient A suffered from immune rejection after liver transplantation. Based on the MALDI-TOF nucleic acid mass spectrometry platform, the detection method of tacrolimus metabolism-related genotyping can detect the hotspot mutation sites related to tacrolimus metabolism in patient A. Site variation information guides patients to rationally use drugs, including the following steps:

[0120] One, design the amplification primer shown in table 8, the extension primer shown in table 9 and the standard product nucleic acid sequence shown in table 10;

[0121] Table 8 Amplification primers of target gene sequence

[0122]

[0123]

[0124] Table 9 Extension primers for the target gene sequence

[0125] target gene sequence extension primer rs2032582 TTAGTTTGACTCACCTTCCCAG (S...

Embodiment 3

[0145] The verification of embodiment 3 reaction system

[0146] During the system optimization process of this example, 2 to 3 samples of each detection site were verified by Sanger sequencing, and the comparison results were all consistent, confirming that the detection results of this example are accurate. In this embodiment, after confirming the optimal reaction system, a series of verification experiments were carried out, including accuracy and precision. The specific verification scheme is as follows:

[0147] (1) Accuracy experimental verification plan: select one sample for each of the three SNP sites for Sanger sequencing, and compare the results of Sanger sequencing and MassARRAY. If the consistency is greater than 95%, the verification is passed.

[0148] (2) Precision experiment verification plan: pick 3 peripheral blood samples and 3 corresponding oral swab samples, repeat 3 times for each sample to conduct a batch of detection, a total of 3 batches were detec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for detecting precise drug use of tacrolimus, primers, PCR reagents and kits, and belongs to the technical field of medical treatment and biological detection. The present invention combines MALDI‑TOF and blood drug concentration monitoring to analyze the impact on tacrolimus metabolism from the aspect of gene polymorphism, as the basis for the application of immunosuppressant tacrolimus, so as to guide doctors according to the genetic status of patients. The use of personalized medicine enables patients to obtain maximum drug efficacy while reducing adverse drug reactions, thus greatly promoting the process of new "individualized medicine", so it has good practical application value.

Description

technical field [0001] The invention belongs to the technical field of medical treatment and biological detection, and in particular relates to a detection method, primers, PCR reagents and a kit for detecting precise drug use of tacrolimus. Background technique [0002] The information disclosed in this background section is only intended to increase the understanding of the general background of the present invention, and is not necessarily taken as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to those skilled in the art. [0003] Tacrolimus (FK506), trade name Prograf, is a new type of macrolide immunosuppressant derived from Streptomyces. Tacrolimus is a calcineurin inhibitor that can selectively inhibit the immunosuppressive response mediated by T cell activation. After tacrolimus enters T lymphocytes, it binds to FK506 binding protein (FKBP) to form a FK506-FKBP complex, which inhibits the activity of calcine...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12Q1/6883C12N15/11
CPCC12Q1/6883C12Q2600/106C12Q2600/156
Inventor 冯振景叶松弭兆元
Owner JINAN YING SHENG BIOTECH